Clinical Trial Update: Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating autologous adipose-derived stromal vascular fraction cells for osteoarthritis; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Degenerative
• Joint Disease
• Osteoarthritis
• Osteoarthritis of the Knee
• Osteoarthrosis
• Osteoarthrosis Deformans

Drugs mentioned

• Autologous adipose-derived stromal vascular fraction (SVF) cells

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Osteoarthritis, Joint Disease | Phase 1, Phase 2 | Status: COMPLETED